Author Topic: USRM (Read 676 times)

Clay Death · « **on:** March 28, 2017, 07:30:27 pm »

U.S. Stem Cell Releases Positive 2016 Financial Results; Highlights Include Increased Revenue, Decreased Liabilities, Decreased Expenses, Net Loss Improvement, and Cash Positive at Year End

SUNRISE, FL / ACCESSWIRE / March 15, 2017 / U.S. Stem Cell, Inc., a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and ani...

Yahoo Finance · finance.yahoo.com

Swish · « **Reply #1 on:** March 28, 2017, 09:47:45 pm »

Good to see you like this one.

It has great potential and it can help a lot of people too.

Today wasn't too good but it's just consolidation.

I'm not too worried about day to day movement, the big prize is FDA approval, anytime now.

What the price will be is up for debate but it will make a lot of people happy.

Clay Death · « **Reply #2 on:** March 29, 2017, 08:03:39 am »

Quote from: Swish on March 28, 2017, 09:47:45 pm

Good to see you like this one.

It has great potential and it can help a lot of people too.

Today wasn't too good but it's just consolidation.

I'm not too worried about day to day movement, the big prize is FDA approval, anytime now.

What the price will be is up for debate but it will make a lot of people happy.

some profit takers took their money and moved on. stock quickly finds other buyers.

no worries.

it is going to be business as usual today at USRM.

It might jump another 20% today.

Clay Death · « **Reply #3 on:** March 30, 2017, 08:59:38 pm »

U.S. Stem Cell, Inc. Working Closely with FDA to Obtain Regenerative Advanced Therapy Designation

SUNRISE, FL / ACCESSWIRE / March 30, 2017 / U.S. Stem Cell, Inc. (USCC) (OTCQB: USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therap...

Yahoo Finance · finance.yahoo.com

Swish · « **Reply #4 on:** March 31, 2017, 03:51:49 pm »

Murphy posted a form 4. He bought shares, about 1.7 mil. This form came out today right after market close.

He wouldn't be buying shares unless he felt the company was going to do well.
And that would be FDA approval.

Everythings adding up nicely on this stock, maybe early next week we get approval.

SEC FORM 4

archive.fast-edgar.com

Clay Death · « **Reply #5 on:** March 31, 2017, 08:49:27 pm »

Quote from: Swish on March 31, 2017, 03:51:49 pm

Murphy posted a form 4. He bought shares, about 1.7 mil. This form came out today right after market close.

He wouldn't be buying shares unless he felt the company was going to do well.
And that would be FDA approval.

Everythings adding up nicely on this stock, maybe early next week we get approval.

http://archive.fast-edgar.com//20170331/A6KZ862CZ22H5ZZ222242ZZMVVS8ZZ223Y92/

wow.

awesome news.

I will be adding/accumulating more next week for sure.

Swish · « **Reply #6 on:** April 26, 2017, 05:36:58 pm »

Still waiting on FDA approval, should be soon. $$$$$$$$$

Clay Death · « **Reply #7 on:** April 26, 2017, 07:08:28 pm »

stock is beaten up and oversold.

should be ready for a breakout soon.

CAMELOT FANTASIES

News:

Author Topic: USRM (Read 676 times)

Clay Death

USRM

Swish

Re: USRM

Clay Death

Re: USRM

Clay Death

Re: USRM

Swish

Re: USRM

Clay Death

Re: USRM

Swish

Re: USRM

Clay Death

Re: USRM

Recent Topics